Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia

This study has been completed.
Sponsor:
Collaborator:
Dong-A Parmaceutical
Information provided by:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01285544
First received: January 9, 2011
Last updated: December 15, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):